Home | Privacy | Contact    

Health Information About Carcinoid Tumors


Carcinoid tumors - MayoClinic.com - Mayo Clinic
http://www.mayoclinic.com/health/carcinoid-tumors/DS00834 Carcinoid tumors — Comprehensive overview covers symptoms, diagnosis, treatment of these rare, slow-growing cancerous tumors. more...
Carcinoid - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Carcinoid Carcinoid (also carcinoid tumor) is a slow-growing type of neuroendocrine tumor, originating in the cells of the neuroendocrine system. In 2000, the World Health ... more...
Carcinoid Tumors: MedlinePlus - National Library of Medicine ...
http://www.nlm.nih.gov/medlineplus/carcinoidtumors.html Carcinoid tumors are rare, slow-growing cancers that usually start in the lining of the digestive tract or in the lungs. Because they grow slowly and don't produce ... more...
Carcinoid Tumors, Gastrointestinal: Information from Answers.com
http://www.answers.com/topic/carcinoid-tumors-gastrointestinal Key Terms: Adrenal gland, Cyanosis, Heart murmur, Hormone. Definition Gastrointestinal carcinoid tumors are rare malignancies in which cancer develops in hormone ... more...
Carcinoid Tumor - Diseases & Conditions - Medscape Reference
http://emedicine.medscape.com/article/986050-overview Carcinoid tumors are derived from primitive stem cells in the gut wall but can be seen in other organs, [1] including the lungs, [2] mediastinum, thymus, [3] liver ... more...



Carcinoid Tumors News


carcinoid tumors - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
Dr. Matthew Kulke is a world expert in neuroendocrine (NET) read more...
55 types of cancer found among Arabs
Other types of cancers common to the region include: intestinal read more...
Novartis drug Signifor® recommended by CHMP for EU approval to treat patients with Cushing's disease
Pasireotide LAR is also being studied in three large-scale, global Phase III clinical trial programs: two in patients with acromegaly and one in patients with metastatic read more...
Novartis Drugs Backed by CHMP
First, the CHMP gave a positive opinion to update the label of its marketed drug Gleevec for extended use of adjuvant treatment for three years in patients with KIT (CD117)-positive gastrointestinal stromal read more...